Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The RNFT2/IL-3Rα axis regulates IL-3 signaling and innate immunity
Yao Tong, Travis B. Lear, John Evankovich, Yanwen Chen, James D. Londino, Michael M. Myerburg, Yingze Zhang, Iulia D. Popescu, John F. McDyer, Bryan J. McVerry, Karina C. Lockwood, Michael J. Jurczak, Yuan Liu, Bill B. Chen
Yao Tong, Travis B. Lear, John Evankovich, Yanwen Chen, James D. Londino, Michael M. Myerburg, Yingze Zhang, Iulia D. Popescu, John F. McDyer, Bryan J. McVerry, Karina C. Lockwood, Michael J. Jurczak, Yuan Liu, Bill B. Chen
View: Text | PDF
Research Article Inflammation Pulmonology

The RNFT2/IL-3Rα axis regulates IL-3 signaling and innate immunity

  • Text
  • PDF
Abstract

Interleukin-3 (IL-3) receptor α (IL-3Rα) is the α subunit of the ligand-specific IL-3R and initiates intracellular signaling in response to IL-3. IL-3 amplifies proinflammatory signaling and cytokine storm in murine sepsis models. Here we found that RNFT2 (RING finger transmembrane-domain containing protein 2, also TMEM118), a previously uncharacterized RING finger ubiquitin E3 ligase, negatively regulated IL-3–dependent cellular responses through IL-3Rα ubiquitination and degradation in the proteasome. In vitro, IL-3 stimulation promoted IL-3Rα proteasomal degradation dependent on RNFT2, and we identified IL-3Rα lysine 357 as a ubiquitin acceptor site. We determined that LPS priming reduces RNFT2 abundance, extends IL-3Rα half-life, and sensitizes cells to the effects of IL-3, acting synergistically to increase proinflammatory signaling. In vivo, IL-3 synergized with LPS to exacerbate lung inflammation in LPS and Pseudomonas aeruginosa–challenged mice; conversely, IL-3 neutralization reduced LPS-induced lung injury. Further, RNFT2 overexpression reduced lung inflammation and injury, whereas Rnft2 knockdown exacerbated inflammatory responses in LPS-induced murine lung injury. Last, we examined RNFT2 and IL-3Rα in human lung explants from patients with cystic fibrosis and also showed that IL-3 is elevated in mechanically ventilated critically ill humans at risk for acute respiratory distress syndrome. These results identify RNFT2 as a negative regulator of IL-3Rα and show a potential role for the RNFT2/IL-3Rα/IL-3 axis in regulating innate immune responses in the lung.

Authors

Yao Tong, Travis B. Lear, John Evankovich, Yanwen Chen, James D. Londino, Michael M. Myerburg, Yingze Zhang, Iulia D. Popescu, John F. McDyer, Bryan J. McVerry, Karina C. Lockwood, Michael J. Jurczak, Yuan Liu, Bill B. Chen

×

Figure 2

RING finger E3 ligase RNFT2 regulates IL-3Rα stability and IL-3 signaling.

Options: View larger image (or click on image) Download as PowerPoint
RING finger E3 ligase RNFT2 regulates IL-3Rα stability and IL-3 signalin...
(A) Immunoblot analysis of IL-3Rα from MLE cells transfected with LacZ or 1 of the other 10 randomly selected RING finger E3 ligases. IL-3Rα/actin densitometry normalized to LacZ treatment is shown below IL-3Rα bands. (B) Immunoblotting of IL-3Rα from MLE cells transfected with a dose course of RNFT2. Data and mean ± SEM of 3 independent experiments. (C) Immunoblot analysis of MLE cells following expression of RNFT2-HA and immunoprecipitation (IP) of RNFT2-HA. (D) Immunoblotting of in vitro ubiquitination assay involving the full complement of ubiquitination machinery (E1, E2, ubiquitin, ATP, Mg2+) and RNFT2 protein. (E) Immunoblot analysis of in vivo ubiquitination assay in MLE cells expressing IL-3Rα-V5-HIS with HA-ubiquitin and RNFT2 before MG132 treatment and HIS tag pull-down of IL-3Rα-V5-HIS. (F) Immunoblotting of in vitro protein binding assay between V5-tagged ubiquitin E2 enzymes (Ub E2) and immunoprecipitated RNFT2 protein (IP RNFT2). TnT, in vitro transcription and translation. (G) Immunoblot analysis of MLE cells expressing RNFT2-HIS-V5 before HIS pull-down of RNFT2. (H) Immunoblot analysis of MLE cells cotransfected with WT or K357R IL-3Rα lysine mutants with or without RNFT2. Data and mean ± SEM of 3 independent experiments. *P < 0.05, ***P < 0.001, and ****P < 0.0001 by 1-way ANOVA with Dunnett’s post hoc test (B) or by 1-way ANOVA with Tukey’s post hoc test (H).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts